Ken Griffin GSK PLC Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024
Number of Shares
710,300
Previous 621,900 14.21%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
N/A
-203,555 Reduced 93.64%
13,829 $0
Q1 2024

May 15, 2024
BUY
N/A
99,049 Added 83.7%
217,384 $0
Q4 2023

Feb 14, 2024
SELL
N/A
-414,275 Reduced 77.78%
118,335 $0
Q3 2023

Nov 14, 2023
BUY
N/A
505,088 Added 1835.22%
532,610 $0
Q2 2023

Aug 14, 2023
SELL
N/A
-250,135 Reduced 90.09%
27,522 $0
Q1 2023

May 15, 2023
SELL
N/A
-655,824 Reduced 70.26%
277,657 $0
Q4 2022

Feb 14, 2023
SELL
N/A
-2,778,462 Reduced 74.85%
933,481 $0
Q3 2022

Nov 14, 2022
BUY
N/A
3,711,943 New
3,711,943 $109 Million
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email